3396:HKEXLegend Holdings Corporation Class H Analysis
Data as of 2026-06-12 - not real-time
HK$15.28
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Legend Holdings trades at HK$15.28, comfortably above its 20‑day SMA of 14.08 and the 50‑day SMA of 11.28, confirming a bullish price trend. The 14‑day RSI sits at 60, indicating momentum but no imminent overbought condition, while the MACD histogram is slightly negative, hinting at a short‑term bearish crossover. Volatility is exceptionally high at 89 % over the past 30 days and the beta of 0.82 suggests the stock moves somewhat less than the market, adding to the risk profile. Valuation metrics are mixed: the trailing P/E of 41.3 exceeds the industry average of 36.5, yet the forward P/E of 9.5 and a price‑to‑book of 0.55 point to potential upside. The dividend yield is modest at 0.73 % with a zero payout ratio, raising questions about sustainability. With support around 9.67 and resistance near 18.64, the stock remains well above its key support but faces a sizable upside gap.
The company’s revenue has contracted by 9.7 % year‑over‑year, and margins are thin, underscoring earnings pressure. However, its diversified portfolio—spanning technology, financial services, agriculture, and real estate—provides multiple avenues for recovery. The decreasing volume trend may limit short‑term liquidity, while the “Extreme Greed” market sentiment (fear‑greed index 86.7) could inflate price expectations. Given the blend of bullish technical signals, attractive forward valuation, and substantial sector‑specific risks, investors should adopt a cautiously optimistic stance.
The company’s revenue has contracted by 9.7 % year‑over‑year, and margins are thin, underscoring earnings pressure. However, its diversified portfolio—spanning technology, financial services, agriculture, and real estate—provides multiple avenues for recovery. The decreasing volume trend may limit short‑term liquidity, while the “Extreme Greed” market sentiment (fear‑greed index 86.7) could inflate price expectations. Given the blend of bullish technical signals, attractive forward valuation, and substantial sector‑specific risks, investors should adopt a cautiously optimistic stance.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price above short‑term moving averages
- MACD bearish histogram signal
- Decreasing volume trend
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Forward P/E around 9.5 suggests upside
- Low price‑to‑book ratio
- Diversified business segments offering earnings recovery potential
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Broad diversification across sectors
- Persistent revenue decline and thin margins
- Regulatory and geopolitical exposure in China
Key Metrics & Analysis
Financial Health
Revenue Growth-9.70%
Profit Margin1.31%
P/E Ratio41.3
P/B Ratio0.5
Industry P/E36.5
Technical Analysis
TrendBullish
RSI60.0
SupportHK$9.67
ResistanceHK$18.64
MA 20HK$14.08
MA 50HK$11.28
MA 200HK$10.09
MACDBearish
VolumeDecreasing
Fear & Greed Index86.71
Valuation
Target PriceHK$13.11
Upside/Downside-14.20%
GradeFair
TypeValue
Dividend Yield0.73%
Risk Assessment
Beta0.82
Volatility89.19%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.